[Physiopathology and treatment of tetanus. 2].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D005260:Female; D050723:Fractures, Bone / Q000209:etiology; D006801:Humans; D007106:Immune Sera / Q000009:adverse effects; D007136:Immunoglobulins; D007231:Infant, Newborn; D001523:Mental Disorders / Q000209:etiology; D009125:Muscle Relaxants, Central / Q000627:therapeutic use; D003473:Neuromuscular Nondepolarizing Agents / Q000627:therapeutic use; D011247:Pregnancy; D013124:Spinal Injuries / Q000209:etiology; D013742:Tetanus / Q000150:complications / Q000188:drug therapy / Q000276:immunology / Q000517:prevention & control / Q000628:therapy*; D013743:Tetanus Antitoxin / Q000627:therapeutic use*; D013744:Tetanus Toxin / Q000008:administration & dosage*; D013745:Tetanus Toxoid / Q000627:therapeutic use; D013997:Time Factors
D000900:Anti-Bacterial Agents; D007106:Immune Sera; D007136:Immunoglobulins; D009125:Muscle Relaxants, Central; D003473:Neuromuscular Nondepolarizing Agents; D013743:Tetanus Antitoxin; D013744:Tetanus Toxin; D013745:Tetanus Toxoid
Physiopathologie et traitement du tétanos. 2.